BDBM723374 1-(5-(8-(4-methyl-6-(5- methyl-1H-pyrazol-3-yl) amino)pyrimidin-2-yl)-3, 8-diazabicyclo[3.2.1] octane-3-carbonyl)pyridin- 2-yl)-1H-pyrazol- 4-carbonitrile::US12234222, Compound I-9

SMILES Cc1cc(Nc2cc(C)[nH]n2)nc(N2C3CCC2CN(C(=O)c2ccc(-n4cc(C#N)cn4)nc2)C3)n1

InChI Key InChIKey=BHDNMZNYEGULRO-UHFFFAOYSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 723374   

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM723374(1-(5-(8-(4-methyl-6-(5- methyl-1H-pyrazol-3-yl) ...)
Affinity DataIC50: 8.60nMAssay Description:The experimental steps are as follows:(1) The test compound (the compound of the present disclosure, and compound 164 in WO2018017983A1 as a control)...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/24/2025
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Zhejiang Hisun Pharmaceutical

US Patent
LigandPNGBDBM723374(1-(5-(8-(4-methyl-6-(5- methyl-1H-pyrazol-3-yl) ...)
Affinity DataIC50: 304nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/24/2025
Entry Details
US Patent